Caspian: Os Results from a Randomised Phase 3 Study of First-Line Durvalumab Tremelimumab plus Chemotherapy in ES-SCLC
ONCOLOGY RESEARCH AND TREATMENT(2020)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined